Search Results
Oct 18, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Cepton, Inc. and Certain Officers - CPTN
Cepton at more than double" the Koito Acquisition. The Amended Complaint further alleges that Cepton's Chief Executive Officer Defendant Jun Pei was subject to conflicts in his negotiations with Koito and encouraged the Board to recommend accepting the Koito Acquisition so as to protect his
More news about: Pomerantz LLP
Oct 17, 2025, 17:39 ET FDA approves Novo Nordisk's oral semaglutide for cardiovascular (CV) risk reduction in adults with type 2 diabetes who are at high risk, including those who have not had a prior CV event
uncontrolled on metformin: the PIONEER 2 trial. Diabetes Care. 2019;42(12):2272-2281. Novo Nordisk Data on File. IQVIA Jun'25 Patients R3M Vol. data. 2025. Novo Nordisk is a registered trademark of Novo Nordisk A/S. ©
More news about: Novo Nordisk
Oct 17, 2025, 17:15 ET FDA approves Novo Nordisk's oral semaglutide for cardiovascular (CV) risk reduction in adults with type 2 diabetes who are at high risk, including those who have not had a prior CV event
2 diabetes uncontrolled on metformin: the PIONEER 2 trial. Diabetes Care. 2019;42(12):2272-2281. Novo Nordisk Data on File. IQVIA Jun'25 Patients R3M Vol. data. 2025. Novo Nordisk is a registered trademark of Novo Nordisk A/S. © 2025 Novo Nordisk
More news about: Novo Nordisk
Oct 17, 2025, 10:00 ET Boehringer's HERNEXEOS® demonstrated a 77% objective response rate in treatment-naïve patients with advanced HER2 (ERBB2)-mutant NSCLC
Valentine, T. R. et al. Illness Perceptions and Psychological and Physical Symptoms in Newly Diagnosed Lung Cancer. Health Psychol. 2022 Jun; 41(6): 379–388. Andersen, B. L. et al. Newly diagnosed patients with advanced non-small cell lung cancer: A clinical description
More news about: Boehringer Ingelheim
Oct 16, 2025, 16:30 ET Simmons First National Corporation Reports Third Quarter 2025 Results
Jun 30
More news about: Simmons First National Corporation
Oct 16, 2025, 08:35 ET Unixell Biotech reported a case study of UX-DA001, an iPSC-derived autologous cell therapy for Parkinson Diseases at MDS Congress 2025
both received clinical trial approval in China and the United States. The study is led by Principal Investigator Dr. Liu Jun, Professor and Director of the Department of Neurology at Ruijin Hospital Affiliated with School of Medicine, Shanghai Jiao
More news about: UniXell Biotechnology
Oct 16, 2025, 08:09 ET Infosys: Quarterly revenue crosses $5 bn mark
collaborated with Glion Arena Kobe as their official digital innovation and GX partner to power smart and sustainable entertainment experiences. Jun Shibuya, President and Representative Director, One Bright KOBE Corporation, said, "Glion Kobe Arena is a new landmark commemorating the 30th anniversary
More news about: Infosys
Oct 16, 2025, 08:05 ET transcosmos and BBF form business alliance in supporting overseas businesses make Japan market entry
(Headquarters: Tokyo, Japan; Representative Director, Co-presidents: Masaaki Muta/Takeshi Kamiya; transcosmos) and BBF, Inc. (Headquarters: Tokyo, Japan; CEO: Jun Tamura; BBF) hereby announce that the two companies have formed a business alliance to help foreign companies make smooth, effective market entry into
More news about: transcosmos inc.
Oct 16, 2025, 08:04 ET Infosys: Quarterly revenue crosses $5 bn mark
collaborated with Glion Arena Kobe as their official digital innovation and GX partner to power smart and sustainable entertainment experiences. Jun Shibuya, President and Representative Director, One Bright KOBE Corporation, said, "Glion Kobe Arena is a new landmark commemorating the 30th anniversary
More news about: Infosys
Oct 15, 2025, 17:19 ET ATLAS OCEAN VOYAGES ANNOUNCES NEW 2027 ARCTIC EXPEDITIONS
Jun 30, 2027 – Polar Circle Odyssey - Reykjavík to Longyearbyen | 10 Nights | World Navigator
More news about: Atlas Ocean Voyages
Oct 15, 2025, 15:35 ET 16th Annual Sohn San Francisco Investment Conference to Convene Leading Investors and Support Local Nonprofits
Capital Shaun Mehra, Founder, Ishara Investments Jun Y. Oh, CIO, Griet Capital Beneficiary Presentation:
More news about: The Sohn Conference Foundation
Oct 15, 2025, 14:27 ET Berger Montague PC Investigates Securities Claims Against Cepton, Inc. (NASDAQ: CPTN)
existence to shareholders in proxy materials for the Koito acquisition. The lawsuit also alleges that Cepton CEO Jun Pei had significant conflicts of interest that influenced the Board's decision-making process. Investors learned the truth about Cepton through documents
More news about: Berger Montague
Oct 15, 2025, 12:00 ET Zillow announces Zillow Pro: A suite of products designed to transform how agents capture business and meet consumer needs
closing. "Zillow is laser-focused on helping real estate agents succeed, and with Zillow Pro, we're deepening that commitment," said Jun Choo, Zillow's chief operating officer. "We're building game-changing technology that enhances the essential relationship between agents and their clients
More news about: Zillow
Oct 15, 2025, 11:00 ET UST anuncia a los ganadores del hackatón global D3CODE 2025 y premia a los innovadores previo a la Conferencia Anual de Tecnología D3
• Jun Quan Chin • Yong
More news about: UST
Oct 15, 2025, 09:00 ET UST Names Global D3CODE 2025 Hackathon Winners and Honors Innovators Ahead of Annual D3 Technology Conference
• Jun Quan Chin • Yong
More news about: UST
Oct 15, 2025, 02:00 ET UST Names Global D3CODE 2025 Hackathon Winners and Honors Innovators Ahead of Annual D3 Technology Conference
• Jun Quan Chin • Yong
More news about: UST
![Le regroupement d'Allwyn et d'OPAP crée le deuxième opérateur de loterie et de jeux de hasard le plus important au monde[1]](https://mma.prnewswire.com/media/2794464/Allwyn_Logo.jpg?w=300){kind=logo}
Oct 14, 2025, 14:12 ET Le regroupement d'Allwyn et d'OPAP crée le deuxième opérateur de loterie et de jeux de hasard le plus important au monde[1]
le BAIIA consolidé LTM Jun-25 pro forma pour les acquisitions annoncées de PrizePicks et Novibet, la clôture étant sujette aux approbations réglementaires et antitrust. Ne comprend pas les opérateurs de casinos réels. [2] Basé sur le BAIIA consolidé LTM Jun-25 pro forma pour les
More news about: Allwyn
Oct 14, 2025, 09:03 ET Co-PSMA trial achieves primary endpoint
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial. JAMA Oncol. 2019 Jun 1;5(6):856-863. doi: 10.1001/jamaoncol.2019.0096. PMID: 30920593; PMCID: PMC6567829. Mena E, Lindenberg ML, Turkbey IB, Shih
More news about: Clarity Pharmaceuticals
Oct 13, 2025, 14:34 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Cepton, Inc. and Certain Officers - CPTN
Cepton at more than double" the Koito Acquisition. The Amended Complaint further alleges that Cepton's Chief Executive Officer Defendant Jun Pei was subject to conflicts in his negotiations with Koito and encouraged the Board to recommend accepting the Koito Acquisition so as to protect his
More news about: Pomerantz LLP
Oct 13, 2025, 10:17 ET Boehringer and Click Therapeutics present pivotal data for investigational prescription digital therapeutic CT-155 showing a statistically significant reduction in negative symptoms of schizophrenia
negative symptoms identified through natural language processing among patients with schizophrenia in the United States. Schizophr Bull. 2025 Jun 3:sbaf073.
More news about: Boehringer Ingelheim Pharmaceuticals, Inc.; Click Therapeutics
Oct 13, 2025, 09:00 ET iRegene Therapeutics announced promising NouvNeu001 Phase I clinical data
single injection trajectory per hemisphere, significantly reducing potential surgical risks and related adverse events." Dr. Jun Wei, Chief Executive Officer of iRegene Therapeutics, added: "The iRegene team is greatly encouraged by this important
More news about: iRegene therapeutics
Oct 13, 2025, 03:54 ET Business Combination of Allwyn and OPAP creating the 2nd Largest Listed Lottery and Gaming Operator Globally[1]
[1] Based on consolidated LTM Jun-25 EBITDA pro forma for announced acquisitions of PrizePicks and Novibet, closing subject to regulatory and anti-trust approvals. Excludes land-based casino operators. [2] Based on consolidated LTM Jun-25 EBITDA pro forma for announced acquisitions
More news about: Allwyn
Oct 13, 2025, 03:47 ET Business Combination of Allwyn and OPAP creating the 2nd Largest Listed Lottery and Gaming Operator Globally[1]
[1] Based on consolidated LTM Jun-25 EBITDA pro forma for announced acquisitions of PrizePicks and Novibet, closing subject to regulatory and anti-trust approvals. Excludes land-based casino operators. [2] Based on consolidated LTM Jun-25 EBITDA pro forma for announced
More news about: Allwyn
Oct 13, 2025, 00:38 ET GC Biopharma Secures CMO Rights for Shingles Vaccine from Curevo Vaccine
Sohee [email protected] Yelin Jun[email protected] Yoonjae Na
More news about: GC Biopharma
Oct 09, 2025, 20:16 ET Seegene y Springer Nature aceptan solicitudes para becas de impacto 2025-2026 Nature Awards MDx
[email protected] Hyeongjoo Park [email protected]Jun Lee [email protected] Min
More news about: Seegene Inc.